BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31134486)

  • 21. [CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].
    Labauge P; Fogli A; Niel F; Rodriguez D; Boespflug-Tanguy O
    Rev Neurol (Paris); 2007 Sep; 163(8-9):793-9. PubMed ID: 17878805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoplasmic reticulum stress intolerance in EIF2B3 mutant oligodendrocytes is modulated by depressed autophagy.
    Chen N; Dai L; Jiang Y; Wang J; Hao H; Ren Y; Leng X; Zang L; Wu Y
    Brain Dev; 2016 May; 38(5):507-15. PubMed ID: 26625702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease.
    Bugiani M; Postma N; Polder E; Dieleman N; Scheffer PG; Sim FJ; van der Knaap MS; Boor I
    Brain; 2013 Jan; 136(Pt 1):209-22. PubMed ID: 23365098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of A1/A2 astrocytes on oligodendrocyte linage cells against white matter injury under prolonged cerebral hypoperfusion.
    Miyamoto N; Magami S; Inaba T; Ueno Y; Hira K; Kijima C; Nakajima S; Yamashiro K; Urabe T; Hattori N
    Glia; 2020 Sep; 68(9):1910-1924. PubMed ID: 32108971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The unfolded protein response in vanishing white matter disease.
    van der Voorn JP; van Kollenburg B; Bertrand G; Van Haren K; Scheper GC; Powers JM; van der Knaap MS
    J Neuropathol Exp Neurol; 2005 Sep; 64(9):770-5. PubMed ID: 16141786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease.
    Wu Y; Pan Y; Du L; Wang J; Gu Q; Gao Z; Li J; Leng X; Qin J; Wu X; Jiang Y
    J Hum Genet; 2009 Feb; 54(2):74-7. PubMed ID: 19158808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.
    van der Knaap MS; Leegwater PA; Könst AA; Visser A; Naidu S; Oudejans CB; Schutgens RB; Pronk JC
    Ann Neurol; 2002 Feb; 51(2):264-70. PubMed ID: 11835386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult mouse eIF2Bε Arg191His astrocytes display a normal integrated stress response in vitro.
    Wisse LE; Ter Braak TJ; van de Beek MC; van Berkel CGM; Wortel J; Heine VM; Proud CG; van der Knaap MS; Abbink TEM
    Sci Rep; 2018 Feb; 8(1):3773. PubMed ID: 29491431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunction.
    Zhou L; Li P; Chen N; Dai LF; Gao K; Liu YN; Shen L; Wang JM; Jiang YW; Wu Y
    CNS Neurosci Ther; 2019 Jun; 25(6):759-771. PubMed ID: 30720246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical effects of mutations in the gene encoding the alpha subunit of eukaryotic initiation factor (eIF) 2B associated with Vanishing White Matter disease.
    Wortham NC; Proud CG
    BMC Med Genet; 2015 Aug; 16():64. PubMed ID: 26285592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretomics Alterations and Astrocyte Dysfunction in Human iPSC of Leukoencephalopathy with Vanishing White Matter.
    Deng J; Zhang J; Gao K; Yan W; Zhou L; Jiang Y; Wang J; Wu Y
    Neurochem Res; 2022 Dec; 47(12):3747-3760. PubMed ID: 36198922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium: effects in animal models of vanishing white matter are not promising.
    Witkamp D; Oudejans E; Hoogterp L; Hu-A-Ng GV; Glaittli KA; Stevenson TJ; Huijsmans M; Abbink TEM; van der Knaap MS; Bonkowsky JL
    Front Neurosci; 2024; 18():1275744. PubMed ID: 38352041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A point mutation in translation initiation factor 2B leads to a continuous hyper stress state in oligodendroglial-derived cells.
    Kantor L; Pinchasi D; Mintz M; Hathout Y; Vanderver A; Elroy-Stein O
    PLoS One; 2008; 3(11):e3783. PubMed ID: 19023445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of eIF2B bodies and their relationships with stress granules and P-bodies.
    Moon SL; Parker R
    Sci Rep; 2018 Aug; 8(1):12264. PubMed ID: 30115954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients.
    Kantor L; Harding HP; Ron D; Schiffmann R; Kaneski CR; Kimball SR; Elroy-Stein O
    Hum Genet; 2005 Oct; 118(1):99-106. PubMed ID: 16041584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severity of vanishing white matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes.
    Liu R; van der Lei HD; Wang X; Wortham NC; Tang H; van Berkel CG; Mufunde TA; Huang W; van der Knaap MS; Scheper GC; Proud CG
    Hum Mutat; 2011 Sep; 32(9):1036-45. PubMed ID: 21560189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy.
    Takano K; Tsuyusaki Y; Sato M; Takagi M; Anzai R; Okuda M; Iai M; Yamashita S; Okabe T; Aida N; Tsurusaki Y; Saitsu H; Matsumoto N; Osaka H
    Brain Dev; 2015 Jun; 37(6):638-42. PubMed ID: 25457085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Three-dimensional Structure of eIF2B: A Clue to Understanding the Pathogenesis of CACH/VWM Disease].
    Kashiwagi K; Ito T; Yokoyama S
    Brain Nerve; 2017 Jan; 69(1):45-50. PubMed ID: 28126977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.
    Fogli A; Wong K; Eymard-Pierre E; Wenger J; Bouffard JP; Goldin E; Black DN; Boespflug-Tanguy O; Schiffmann R
    Ann Neurol; 2002 Oct; 52(4):506-10. PubMed ID: 12325082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. eIF2B activator prevents neurological defects caused by a chronic integrated stress response.
    Wong YL; LeBon L; Basso AM; Kohlhaas KL; Nikkel AL; Robb HM; Donnelly-Roberts DL; Prakash J; Swensen AM; Rubinstein ND; Krishnan S; McAllister FE; Haste NV; O'Brien JJ; Roy M; Ireland A; Frost JM; Shi L; Riedmaier S; Martin K; Dart MJ; Sidrauski C
    Elife; 2019 Jan; 8():. PubMed ID: 30624206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.